NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES
|
0.500 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
De Novo Variants in GRIA4 Lead to Intellectual Disability with or without Seizures and Gait Abnormalities.
|
29220673 |
2017 |
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES
|
0.500 |
GeneticVariation
|
disease |
UNIPROT |
De Novo Variants in GRIA4 Lead to Intellectual Disability with or without Seizures and Gait Abnormalities.
|
29220673 |
2017 |
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES
|
0.500 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
De Novo Variants in GRIA4 Lead to Intellectual Disability with or without Seizures and Gait Abnormalities.
|
29220673 |
2017 |
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES
|
0.500 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Absence seizures in C3H/HeJ and knockout mice caused by mutation of the AMPA receptor subunit Gria4.
|
18316356 |
2008 |
Myopia
|
0.400 |
GeneticVariation
|
disease |
GWASCAT |
Detection and interpretation of shared genetic influences on 42 human traits.
|
27182965 |
2016 |
Myopia
|
0.400 |
Biomarker
|
disease |
CTD_human |
Genome-wide meta-analyses of multiancestry cohorts identify multiple new susceptibility loci for refractive error and myopia.
|
23396134 |
2013 |
Schizophrenia
|
0.350 |
GeneticVariation
|
disease |
BEFREE |
Our findings provide no evidence for an association between SNPs within GRIA1, GRIA2 and GRIA4 under investigation and schizophrenia susceptibility, although rs3813296 (GRIA2) could be associated with improvement on PANSS negative scores.
|
22094384 |
2012 |
Schizophrenia
|
0.350 |
Biomarker
|
disease |
PSYGENET |
Our findings provide no evidence for an association between SNPs within GRIA1, GRIA2 and GRIA4 under investigation and schizophrenia susceptibility, although rs3813296 (GRIA2) could be associated with improvement on PANSS negative scores.
|
22094384 |
2012 |
Schizophrenia
|
0.350 |
Biomarker
|
disease |
PSYGENET |
No evidence of association with schizophrenia was found for the GRIA2 and GRIA4 genes; strong evidence of association with schizophrenia was found for GRIA3.
|
18163426 |
2008 |
Schizophrenia
|
0.350 |
GeneticVariation
|
disease |
BEFREE |
No evidence of association with schizophrenia was found for the GRIA2 and GRIA4 genes; strong evidence of association with schizophrenia was found for GRIA3.
|
18163426 |
2008 |
Schizophrenia
|
0.350 |
Biomarker
|
disease |
LHGDN |
No evidence of association with schizophrenia was found for the GRIA2 and GRIA4 genes; strong evidence of association with schizophrenia was found for GRIA3.
|
18163426 |
2008 |
Schizophrenia
|
0.350 |
Biomarker
|
disease |
BEFREE |
We found decreased GluR2 subunit expression in all three illnesses, decreased GluR3 in major depression, and decreased GluR4 in schizophrenia.
|
16983646 |
2006 |
Schizophrenia
|
0.350 |
Biomarker
|
disease |
PSYGENET |
We found decreased GluR2 subunit expression in all three illnesses, decreased GluR3 in major depression, and decreased GluR4 in schizophrenia.
|
16983646 |
2006 |
Schizophrenia
|
0.350 |
Biomarker
|
disease |
PSYGENET |
Our results suggest that the three SNPs of GRIA4 are unlikely to play a major role in the susceptibility to schizophrenia in the Chinese population.
|
15450689 |
2004 |
Schizophrenia
|
0.350 |
GeneticVariation
|
disease |
BEFREE |
Our results suggest that the three SNPs of GRIA4 are unlikely to play a major role in the susceptibility to schizophrenia in the Chinese population.
|
15450689 |
2004 |
Schizophrenia
|
0.350 |
GeneticVariation
|
disease |
BEFREE |
These results suggest that at least one susceptibility locus for schizophrenia is located within or very close to the GRIA4 region in Japanese.
|
12497607 |
2003 |
Schizophrenia
|
0.350 |
GeneticVariation
|
disease |
LHGDN |
These results suggest that at least one susceptibility locus for schizophrenia is located within or very close to the GRIA4 region in Japanese.
|
12497607 |
2003 |
Unipolar Depression
|
0.340 |
GeneticVariation
|
disease |
BEFREE |
An intronic variant at the GRIA4 locus, rs68081839, was significantly associated with ND-MD comorbidity (β = 0.69 [95% CI, 0.43-0.89], P = 1.53 × 10<sup>-8</sup>).
|
30287806 |
2018 |
Major Depressive Disorder
|
0.340 |
GeneticVariation
|
disease |
BEFREE |
An intronic variant at the GRIA4 locus, rs68081839, was significantly associated with ND-MD comorbidity (β = 0.69 [95% CI, 0.43-0.89], P = 1.53 × 10<sup>-8</sup>).
|
30287806 |
2018 |
Unipolar Depression
|
0.340 |
GeneticVariation
|
disease |
BEFREE |
A genetic variant in miRNA binding site of glutamate receptor 4, metabotropic (GRM4) is associated with increased risk of major depressive disorder.
|
27792966 |
2017 |
Major Depressive Disorder
|
0.340 |
GeneticVariation
|
disease |
BEFREE |
A genetic variant in miRNA binding site of glutamate receptor 4, metabotropic (GRM4) is associated with increased risk of major depressive disorder.
|
27792966 |
2017 |
Unipolar Depression
|
0.340 |
GeneticVariation
|
disease |
BEFREE |
Investigation of possible epistatic interactions between GRIA2 and GRIA4 variants on clinical outcomes in patients with major depressive disorder.
|
23613500 |
2013 |
Major Depressive Disorder
|
0.340 |
GeneticVariation
|
disease |
BEFREE |
These data potentially suggest a lack of epistatic interaction between GRIA2 and GRIA4 variants, regarding clinical outcomes in patients with MDD.
|
23613500 |
2013 |
Unipolar Depression
|
0.340 |
GeneticVariation
|
disease |
BEFREE |
Influence of GRIA1, GRIA2 and GRIA4 polymorphisms on diagnosis and response to treatment in patients with major depressive disorder.
|
22057216 |
2012 |
Major Depressive Disorder
|
0.340 |
GeneticVariation
|
disease |
BEFREE |
Influence of GRIA1, GRIA2 and GRIA4 polymorphisms on diagnosis and response to treatment in patients with major depressive disorder.
|
22057216 |
2012 |